Cargando…
P1545: DURABILITY OF HEMOGLOBIN RESPONSE AND REDUCTION IN TRANSFUSION BURDEN IS MAINTAINED OVER TIME IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT IN A LONG-TERM EXTENSION STUDY
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431292/ http://dx.doi.org/10.1097/01.HS9.0000849036.11558.e5 |
_version_ | 1784780014163591168 |
---|---|
author | Grace, R. F. Glenthøj, A. Barcellini, W. Verhovsek, M. Rothman, J. A. Morado Arias, M. Layton, D. M. Andres, O. Galactéros, F. van Beers, E. J. Onodera, K. Viprakasit, V. Chonat, S. Porter, J. B. Judge, M. P. Kosinski, P. A. Hawkins, P. Gheuens, S. Xu, R. McGee, B. Beynon, V. Al-Samkari, H. |
author_facet | Grace, R. F. Glenthøj, A. Barcellini, W. Verhovsek, M. Rothman, J. A. Morado Arias, M. Layton, D. M. Andres, O. Galactéros, F. van Beers, E. J. Onodera, K. Viprakasit, V. Chonat, S. Porter, J. B. Judge, M. P. Kosinski, P. A. Hawkins, P. Gheuens, S. Xu, R. McGee, B. Beynon, V. Al-Samkari, H. |
author_sort | Grace, R. F. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9431292 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94312922022-08-31 P1545: DURABILITY OF HEMOGLOBIN RESPONSE AND REDUCTION IN TRANSFUSION BURDEN IS MAINTAINED OVER TIME IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT IN A LONG-TERM EXTENSION STUDY Grace, R. F. Glenthøj, A. Barcellini, W. Verhovsek, M. Rothman, J. A. Morado Arias, M. Layton, D. M. Andres, O. Galactéros, F. van Beers, E. J. Onodera, K. Viprakasit, V. Chonat, S. Porter, J. B. Judge, M. P. Kosinski, P. A. Hawkins, P. Gheuens, S. Xu, R. McGee, B. Beynon, V. Al-Samkari, H. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431292/ http://dx.doi.org/10.1097/01.HS9.0000849036.11558.e5 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Grace, R. F. Glenthøj, A. Barcellini, W. Verhovsek, M. Rothman, J. A. Morado Arias, M. Layton, D. M. Andres, O. Galactéros, F. van Beers, E. J. Onodera, K. Viprakasit, V. Chonat, S. Porter, J. B. Judge, M. P. Kosinski, P. A. Hawkins, P. Gheuens, S. Xu, R. McGee, B. Beynon, V. Al-Samkari, H. P1545: DURABILITY OF HEMOGLOBIN RESPONSE AND REDUCTION IN TRANSFUSION BURDEN IS MAINTAINED OVER TIME IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT IN A LONG-TERM EXTENSION STUDY |
title | P1545: DURABILITY OF HEMOGLOBIN RESPONSE AND REDUCTION IN TRANSFUSION BURDEN IS MAINTAINED OVER TIME IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT IN A LONG-TERM EXTENSION STUDY |
title_full | P1545: DURABILITY OF HEMOGLOBIN RESPONSE AND REDUCTION IN TRANSFUSION BURDEN IS MAINTAINED OVER TIME IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT IN A LONG-TERM EXTENSION STUDY |
title_fullStr | P1545: DURABILITY OF HEMOGLOBIN RESPONSE AND REDUCTION IN TRANSFUSION BURDEN IS MAINTAINED OVER TIME IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT IN A LONG-TERM EXTENSION STUDY |
title_full_unstemmed | P1545: DURABILITY OF HEMOGLOBIN RESPONSE AND REDUCTION IN TRANSFUSION BURDEN IS MAINTAINED OVER TIME IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT IN A LONG-TERM EXTENSION STUDY |
title_short | P1545: DURABILITY OF HEMOGLOBIN RESPONSE AND REDUCTION IN TRANSFUSION BURDEN IS MAINTAINED OVER TIME IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT IN A LONG-TERM EXTENSION STUDY |
title_sort | p1545: durability of hemoglobin response and reduction in transfusion burden is maintained over time in patients with pyruvate kinase deficiency treated with mitapivat in a long-term extension study |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431292/ http://dx.doi.org/10.1097/01.HS9.0000849036.11558.e5 |
work_keys_str_mv | AT gracerf p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy AT glenthøja p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy AT barcelliniw p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy AT verhovsekm p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy AT rothmanja p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy AT moradoariasm p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy AT laytondm p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy AT andreso p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy AT galacterosf p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy AT vanbeersej p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy AT onoderak p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy AT viprakasitv p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy AT chonats p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy AT porterjb p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy AT judgemp p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy AT kosinskipa p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy AT hawkinsp p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy AT gheuenss p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy AT xur p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy AT mcgeeb p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy AT beynonv p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy AT alsamkarih p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy |